Project Grant R44AA026234

This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $844,475 to the University of Alabama at Birmingham (UAB) to test a bundled intervention aimed at increasing treatment uptake for patients with opioid use disorder (OUD) and nonfatal opioid overdoses after emergency department (ED) discharge. The proposed intervention combines telehealth, peer support, buprenorphine prescribing, and linkage to...

Federal Grant Award Summary The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded Massachusetts General Hospital a $735,930 Project Grant (R34) on September 23, 2025, under the Alcohol Research Programs (CFDA 93.273) to develop, validate, and conduct a feasibility and acceptability study of a large language model (LLM)-based conversational agent for brief alcohol intervention among emerging adults (EAs) ages 18-29. The primary deliverable is an innovative digital intervention...

Federal Grant Award Summary The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a Project Grant totaling $720,043 to The Research Foundation for the State University of New York (SUNY at Binghamton) under the Alcohol Research Programs (CFDA 93.273) to conduct a rigorous, long-term randomized clinical trial examining the efficacy of combining eCheckup To Go (ECTG)—a brief, web-based personalized feedback intervention—with a parent-based intervention to reduce high school...

The National Institute on Drug Abuse (NIDA) awarded a $1,873,868 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Washington University in St. Louis. The grant is for the "Substance Use in Pregnant People - Optimizing Retention in Treatment by Maximizing Opportunities for Management (SUPPORT-MOM)" project, which aims to develop and test the efficacy of contingency management (CM) interventions to improve substance use disorder (SUD) treatment...

The National Science Foundation (NSF) Division of Information and Intelligent Systems awarded a $162,827 Project Grant to the University of Wisconsin - Madison, through the University of Wisconsin System, to develop an "Intelligent Pervasive Augmented Reality Therapy (IPAL)" system for managing opioid use disorder (OUD) and addiction. The 1-year project will integrate complementary psychotherapies like cognitive behavioral therapy and heart rate variability biofeedback with immersive...

This $5.37 million project grant from the National Institutes of Health National Institute on Drug Abuse will fund the development of a context-aware digital adherence intervention called SMARTSTEPS to improve pre-exposure prophylaxis (PrEP) adherence among men who have sex with men with substance use disorder. The grant will support two phases. Phase I will inform the specification of an algorithm that utilizes digital phenotyping data from a smartphone app to anticipate non-adherence based...

Summary: Rigorous Evaluation of Community-Delivered Buprenorphine for Homeless Populations King County Public Health-Seattle & King County received a $350,000 cooperative agreement from the Centers for Disease Control and Prevention (CDC) under the Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136) to conduct a rigorous evaluation of community-delivered short- and long-acting buprenorphine treatments for people experiencing homelessness or residing in...

Federal Project Grant Award Summary The University of Connecticut Health Center received a $172,075 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and test implementation strategies for expanding access to long-acting injectable medications for opioid use disorders (MOUD) in Certified Community Behavioral Health Clinics (CCBHCs). The two-phase R34 project, initiated May 15, 2026 and concluding March...

Federal Cooperative Agreement Summary The National Institute on Drug Abuse (NIDA) awarded a $2.53 million Cooperative Agreement (CFDA 93.279: Drug Use and Addiction Research Programs) to the University of Wisconsin-Madison on September 15, 2025, to conduct a three-arm comparative effectiveness cluster randomized controlled trial evaluating implementation science approaches for scaling medications for opioid use disorder (MOUD) across 120 prisons in 12 states through May 31, 2030. The research...

This $668,110 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development and acceptability testing of a technology-based intervention to reduce cannabis misuse among college students. The project aims to refine an existing intervention that provides information on cannabis products, marketing, laws, and risks to increase young adults' cannabis literacy. The research will involve focus groups with...